The Tobacco Product Prevalence Study (TPPS) was launched in 2021 with the aim of providing estimates of the prevalence of use of over 20 ENDS brands and over 215 individual ENDS devices in the United States. From 2023, TPPS has been extended to provide prevalence of use estimates for nicotine pouches and heated tobacco products. 

TPPS data can be submitted to the United States Food and Drug Administration (FDA) Centre for Tobacco Products (CTP) as part of the evidence map required in a Premarket Tobacco Product Application (PMTA) submission to determine if a product is “appropriate for the protection of the public health”, the legally required standard as set out in the Family Smoking Prevention and Tobacco Control Act 2009.